These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 27118646)

  • 61. High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size.
    Ulger S; Demirci NY; Eroglu FN; Cengiz HH; Tunc M; Tatci E; Yilmaz U; Cetin E; Avci E; Cengiz M
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):495-502. PubMed ID: 24474555
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study.
    Suzuki H; Kato K; Nishio M; Tamaki T; Fujimoto Y; Hiramatsu M; Hanai N; Kodaira T; Itoh Y; Naganawa S; Sone M; Hasegawa Y
    Ann Nucl Med; 2017 Aug; 31(7):514-520. PubMed ID: 28470631
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer.
    Park SY; Lee SJ; Han JH; Koh YW
    Neoplasma; 2019 Jul; 66(4):619-626. PubMed ID: 30868898
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
    Zhang Y; Li WF; Mao YP; Zhou GQ; Peng H; Sun Y; Liu Q; Chen L; Ma J
    Oncotarget; 2016 Mar; 7(12):13612-20. PubMed ID: 26871291
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer.
    Geredeli C; Artac M; Kocak I; Koral L; Sakin A; Altinok T; Kaya B; Karaagac M
    J Cancer Res Ther; 2020; 16(4):816-821. PubMed ID: 32930124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation analysis between the SUVmax of FDG-PET/CT and clinicopathological characteristics in oral squamous cell carcinoma.
    Zheng D; Niu L; Liu W; Zheng C; Yan R; Gong L; Dong Z; Li K; Fei J
    Dentomaxillofac Radiol; 2019 Jul; 48(5):20180416. PubMed ID: 30794427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    Hyun SH; Lee KH; Choi JY; Kim BT; Kim J; Zo JI; Kim H; Kwon OJ; Ahn HK
    PLoS One; 2015; 10(12):e0145020. PubMed ID: 26684001
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation.
    Li M; Sun Y; Liu Y; Han A; Zhao S; Ma L; Zheng J; Yu J
    Lung Cancer; 2010 Jun; 68(3):394-7. PubMed ID: 19683358
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
    J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
    J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
    Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ
    Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis.
    Chen J; Xia J; Huang J; Xu R
    BMC Cancer; 2020 Jun; 20(1):510. PubMed ID: 32493238
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pretreatment
    Satoh Y; Motosugi U; Saito A; Omiya Y; Onishi H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794934. PubMed ID: 30222060
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
    Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Maruo T; Naganawa S; Hasegawa Y; Nakashima T
    Ann Nucl Med; 2013 Apr; 27(3):297-302. PubMed ID: 23337965
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.
    Domachevsky L; Groshar D; Galili R; Saute M; Bernstine H
    Eur Radiol; 2015 Nov; 25(11):3361-7. PubMed ID: 25929940
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.
    Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Shirabe K
    Anticancer Res; 2018 Aug; 38(8):4927-4931. PubMed ID: 30061271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.